Table 3.
Weight loss and comorbidities outcomes
| Initial | After IGB | 1 year after MBS | 2 years after MBS | |
|---|---|---|---|---|
| Weight (kg); median (IQR) | 150.5 (31,0) | 130.5 (31.5) | 95 (32) | 94 (32) |
| BMI (kg/m2); median (IQR) | 58.8 (8) | 50.9 (9.8) | 37.2 (10.4) | 37.9 (11.2) |
| %TWL; mean (SD) | 14.2 (8.5) | 28.9 (13.7) | 27.8 (12.6) | |
| DM2; n/total | 19/51 | 19/51 | 14/51 | 9/51 |
| HT; n/total | 33/51 | 34/51 | 24/51 | 24/51 |
| Dyslipidemia; n/total | 19/51 | 25/51 | 22/51 | 19/51 |
| OSA; n/total | 35/51 | 29/51 | 13/50 | 10/51 |
SD, standard deviation; IQR, interquartile range; IGB, intragastric balloon; MBS, metabolic and bariatric surgery; TWL, total weight loss; %TWL, percentage of total weight loss; DM2, type 2 diabetes mellitus; HT, hypertension; OSA, obstructive sleep apnea